Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
US Army
Express Scripts

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,550,165

« Back to Dashboard

Summary for Patent: 5,550,165

Title: Pharmaceutical compositions for the treatment of hereditary tyosinemia type I
Abstract:The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I.
Inventor(s): Ellis; Martin K. (Macclesfield, GB2), Lindstedt; Sven T. (Lund, SE), Lock; Edward A. (Wilmslow, GB2), Markstedt; Maj E. H. (Billdal, SE), Mutter; Linda C. (Bloomfield, CA), Prisbylla; Michael P. (Richmond, CA)
Assignee: Zeneca Limited (London, GB2)
Application Number:08/359,361
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Formulation; Dosage form;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,550,165

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9113622Jun 24, 1991
United Kingdom9206412Mar 24, 1992

International Patent Family for Patent: 5,550,165

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office0591275► SubscribeCA 2005 00029Denmark► Subscribe
European Patent Office0591275► Subscribe91180Luxembourg► Subscribe
European Patent Office0591275► SubscribeSPC/GB05/030United Kingdom► Subscribe
European Patent Office0591275► Subscribe05C0024France► Subscribe
European Patent Office0591275► SubscribeC300198Netherlands► Subscribe
European Patent Office0591275► Subscribe24/2005Austria► Subscribe
Spain2129448► Subscribe
United Kingdom9113622► Subscribe
Canada2072047► Subscribe
Germany69228813► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus